Moclobemide affects pharmacokinetics of oral rizatriptan

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 1999年 / 764卷 / 1期
关键词：
Placebo; Healthy Volunteer; Single Dose; Clinical Pharmacology; Monoamine;
D O I：
10.2165/00128415-199907640-00007
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [21] PHARMACOKINETICS OF ORAL MOCLOBEMIDE IN HEALTHY-HUMAN SUBJECTS AND EFFECTS ON MAO-ACTIVITY IN PLATELETS AND EXCRETION OF URINE MONOAMINE METABOLITES
    WIESEL, FA
    RAAFLAUB, J
    KETTLER, R
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (01) : 89 - 95
  • [22] A novel rizatriptan oral gel formulation: Bioavailability and bioequivalence
    Tellone, Valeria
    Dragone, Patrizia
    Picollo, Rossella
    Rosignoli, Maria Teresa
    Garofolo, Fabio
    Del Vecchio, Alessandra
    Calisti, Fabrizio
    Comandini, Alessandro
    Donath, Frank
    Schug, Barbara
    Wedemeyer, Ralph-Steven
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2020, 58 (10) : 583 - 594
  • [23] Pharmacokinetics of rizatriptan in patients with mild-moderate hepatic insufficiency.
    Goldberg, MR
    Lee, Y
    Panebianco, D
    Noveck, RJ
    Brucker, MJ
    McLoughlin, DA
    Olah, TV
    Shadle, CR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 186 - 186
  • [24] Pharmacokinetics (PK) of intravenous (IV) rizatriptan (R) in healthy females.
    Rogers, JD
    Lee, Y
    Goldberg, MR
    Ermlich, S
    Brucker, MJ
    McLoughlin, DA
    Olah, TV
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 142 - 142
  • [25] SINGLE-DOSE PHARMACOKINETICS OF THE MAO-INHIBITOR MOCLOBEMIDE IN MAN
    RAAFLAUB, J
    HAEFELFINGER, P
    TRAUTMANN, KH
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1984, 34-1 (01): : 80 - 82
  • [26] Oral rizatriptan versus oral sumatriptan: A direct comparative study in the acute treatment of migraine
    Tfelt-Hansen, P
    Teall, J
    Rodriguez, F
    Giacovazzo, M
    Paz, J
    Malbecq, W
    Block, GA
    Reines, SA
    Visser, WH
    HEADACHE, 1998, 38 (10): : 748 - 755
  • [27] INTERACTION BETWEEN MOCLOBEMIDE AND ORAL TYRAMINE IN DEPRESSED-PATIENTS
    BURGESS, CD
    MELLSOP, GW
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1989, 3 (01) : 47 - 52
  • [28] Posaconazole affects antiviral pharmacokinetics
    Reactions Weekly, 2009, 1267 (1) : 5 - 5
  • [29] Fluoxetine affects the pharmacokinetics of metoclopramide
    Reactions Weekly, 2006, 1128 (1) : 4 - 4
  • [30] Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: A comparative open trial
    Mathew, NT
    Kailasam, J
    Gentry, P
    Chernyshev, O
    HEADACHE, 2000, 40 (06): : 464 - 465
12345